newsfilter
← Latest News
GlobeNewswire·

Evelo Biosciences Announces Fourth Quarter and Full Year 2021 Financial Results and Business Highlights

–Oral presentation on EDP1815 Phase 2 data in psoriasis accepted in late-breaking abstract session at AAD on Saturday, March 26, 2022 ––Positive data reported on faster release capsule––Phase 2 data from EDP1815 in atopic dermatitis on-track fo